Overview

Tear Concentrations and Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers

Status:
Unknown status
Trial end date:
2017-12-31
Target enrollment:
Participant gender:
Summary
To evaluate azithromycin tear concentrations after one drop of azithromycin eyedrops (2.5ml/25mg) in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Beijing Tongren Hospital
Collaborators:
Grand Pharma (China) Co., Ltd
Grand Pharmaceutical (China) Co., Ltd.
Treatments:
Azithromycin
Ophthalmic Solutions
Tetrahydrozoline